| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/08/2001 | CN1069210C Liquid for curing scald and burn and its preparing method |
| 08/08/2001 | CN1069197C Pharmaceutical formulation containing dirithromycin |
| 08/08/2001 | CN1069196C Application of rifampicin in linxiao'an medicine for treating gonorrhea |
| 08/08/2001 | CN1069195C Prep. of suspendible composition |
| 08/08/2001 | CN1069194C Combined construction method of concretepouring and grouting for inclined shafts and vertical shafts |
| 08/08/2001 | CN1069193C Prep. of ointments containing tricyclic compound |
| 08/08/2001 | CN1069192C Aerosol preparation and preparation method thereof |
| 08/08/2001 | CN1069191C Compressed gas packagings using polyoxyethylene glyleryl oleates description |
| 08/08/2001 | CN1069169C Applying formulations containing glycols and/or glycerides |
| 08/07/2001 | USRE37314 Pyrimidine derivatives |
| 08/07/2001 | US6271615 Brush holder |
| 08/07/2001 | US6271396 Use of organosulfur compounds for effecting a bathocromic shift in the UV/vis absorption bands of carotenoids |
| 08/07/2001 | US6271390 Suppression of the IgE-dependent allergic response by benzimidazole analogs |
| 08/07/2001 | US6271384 Self-assembled taxo-diterpenoid nanostructures |
| 08/07/2001 | US6271383 Antibiotic oxazolidinone derivatives |
| 08/07/2001 | US6271376 Process for the preparation of N-(amino-4,6-dihalo-pyrimidine) formamides |
| 08/07/2001 | US6271374 Stable crystalline (6S)- and (6R)-tetrahydrofolic acid |
| 08/07/2001 | US6271373 Compounds, compositions and methods for treating influenza |
| 08/07/2001 | US6271357 Oligonucleotide mimics having nitrogen-containing linkages |
| 08/07/2001 | US6271353 Antibodies specific for human adseverin |
| 08/07/2001 | US6271342 Sugar-modified cytostatics |
| 08/07/2001 | US6271307 Drugs with polyether copolymers with unsaturated ester, vinyl ethers, amides or acids |
| 08/07/2001 | US6271278 Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties |
| 08/07/2001 | US6271268 Treatment of gland disorders with antisecretory agents such as acyl coa cholesterol acyl transferase(acat) inhibitors or prodrugs |
| 08/07/2001 | US6271267 Compound to regulate the morphological transition of dimorphic candida |
| 08/07/2001 | US6271266 Use of idebenone and analogues against β amyloid induced cytotoxicity |
| 08/07/2001 | US6271265 Amide therapeutics for the treatment of inflammatory bowel disease |
| 08/07/2001 | US6271264 Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants |
| 08/07/2001 | US6271263 Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| 08/07/2001 | US6271262 Metalloproteinase inhibitors |
| 08/07/2001 | US6271261 Chemokine mediated diseases, binding interleukins or beta-receptors and administering to mammals |
| 08/07/2001 | US6271260 Biological antigrowth agents for hair |
| 08/07/2001 | US6271259 Method for improving the brain function, inhibiting glutamate excitotoxicity and rescuing from neuronal death |
| 08/07/2001 | US6271257 Decreasing the intracellular level of β-catenin by administering hydroxymatairesinol |
| 08/07/2001 | US6271256 Treating disorders of mammalian gastrointestinal tract with polyether ionophore antibiotics (nigericin, monensin, and calcimysin derivatives) |
| 08/07/2001 | US6271254 Producing cytoprotective effect in a person via administering isomers of alpha-lipoic acid on carriers (stabilizers and solubilizers); useful in treating pain and inflammation |
| 08/07/2001 | US6271253 Cyclooxygenase inhibitors |
| 08/07/2001 | US6271252 Cyclic amino acid derivatives as cell adhesion inhibitors |
| 08/07/2001 | US6271250 Metal Glycididaagolc, and preparation and uses thereof |
| 08/07/2001 | US6271249 Diphenyl imidazoles as potassium channel modulators |
| 08/07/2001 | US6271248 Substituted biphenysulfonamide endothelin antagonists |
| 08/07/2001 | US6271247 Binding to neuropeptide receptors |
| 08/07/2001 | US6271246 Antidandruff composition with acidic component having alpha-or beta-hydroxy acid or tannic acid which exfoliates scalp; vitamin a component inhibits overproducing stratum corneum; antigrowth agent inhibits fungus, yeast, and bacteria |
| 08/07/2001 | US6271245 Hydroxamic acid derivatives |
| 08/07/2001 | US6271244 N-linked urea or carbamate of heterocyclic thioester hair growth compositions and uses |
| 08/07/2001 | US6271243 Pharmaceutical composition |
| 08/07/2001 | US6271242 Adminstering (8r*,9s*,11s*)-(-)-9-hydroxy-9-methoxycarbonyl-8-methyl-2,3,9,10-tetrahydro -8,11-epoxy-(1h, 8h, 11h) 2, 7b, 11a-triazadibenzo(a, g)cycloocta(c,d,e)triinden-1-one as treatment of cancer induced by trk oncogene protein |
| 08/07/2001 | US6271240 Prolonged, controlled administration of nalmefene, coadministered with bupropion, in steady state plasma concentration; achieved via sustained release delivery system (transdermal patch) |
| 08/07/2001 | US6271239 Delta opioid receptor-selective benzylidene-substituted morphinans |
| 08/07/2001 | US6271238 Useful in treating and preventing diseases involving chymotrypsin type proteases which are related to asthma, allergy, inflammations, rheumatism, hypertension, heart failure, myocardial infarction, and cardiac hypertrophy |
| 08/07/2001 | US6271236 Diaminopyridine-containing thiourea inhibitors of herpes virus |
| 08/07/2001 | US6271235 HIV protease inhibitors |
| 08/07/2001 | US6271233 Method for treating ocular neovascular diseases |
| 08/07/2001 | US6271230 Use of NK-1 receptor antagonists for treating cognitive disorders |
| 08/07/2001 | US6271228 Blood pressure stabilization during hemodialysis |
| 08/07/2001 | US6271227 Anticoagulants |
| 08/07/2001 | US6271225 Fused thiophene compounds and medicinal use thereof |
| 08/07/2001 | US6271224 Vision defects |
| 08/07/2001 | US6271223 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action |
| 08/07/2001 | US6271222 Antibiotic |
| 08/07/2001 | US6271221 Alzheimer's disease, antiinflammatory agents, antiarthritic agent |
| 08/07/2001 | US6271220 Anticancer, antiarthritic agents |
| 08/07/2001 | US6271219 Topical formulations comprising skin penetration agents and the use thereof |
| 08/07/2001 | US6271218 Method for inhibiting deoxyribonucleotide triphosphate biosynthesis |
| 08/07/2001 | US6271217 Method of treating cancer with a benzimidazole and a chemotherapeutic agent |
| 08/07/2001 | US6271215 For humans or animals |
| 08/07/2001 | US6271214 Process for the preparation of immunomodulatory polysaccharides from aloe |
| 08/07/2001 | US6271213 Aminosugar, glycosaminoglycan, and S-adenosylmethionine composition for the treatment and repair of connective tissue |
| 08/07/2001 | US6271212 Mixture with carrier |
| 08/07/2001 | US6271210 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for cancer |
| 08/07/2001 | US6271209 Cationic lipid formulation delivering nucleic acid to peritoneal tumors |
| 08/07/2001 | US6271200 Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles |
| 08/07/2001 | US6271199 Treatment of infarcts |
| 08/07/2001 | US6271196 Polypeptide |
| 08/07/2001 | US6271030 For modulation of c/ebp beta (transcription factor enhancer-binding gene) expression and for treatment of diseases associated with expression of c/ebp beta |
| 08/07/2001 | US6271029 Antisense inhibition of cytohesin-2 expression |
| 08/07/2001 | US6271019 Leukemia associated genes |
| 08/07/2001 | US6271015 A polypeptide having an amino acid sequence that hydrolysizes cis-9,10-octadecenoamide and other soporific fatty acid amides; therapy for sleep disorders and narcolepsy |
| 08/07/2001 | US6270979 Screening for modulators of preferential recptor activity; incubate cells and narcotic analgesic and monitor receptor activity in the presence and absence of modulator |
| 08/07/2001 | US6270954 Contacting first cell that expresses confonnationally defective target protein with protein stabilizing agent to improve conformational defect, thereby improving phenotypic defect of first cell where in congo red is not the stabilizer |
| 08/07/2001 | US6270808 Anti-viral isolates obtainable from leeches |
| 08/07/2001 | US6270805 Two pellet controlled release formulation for water soluble drugs which contains an alkaline metal stearate |
| 08/07/2001 | US6270799 1-cyclopropyl-7-((s,s)-2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluo ro-1, 4-dihydro-8-methoxy-4-oxo-3-quino-lonecarboxylic acid and/or pharmaceutically tolerable salts |
| 08/07/2001 | US6270797 Sustained release pharmaceutical composition containing glipizide and method for producing same |
| 08/07/2001 | US6270796 Antihistamine/decongestant regimens for treating rhinitis |
| 08/07/2001 | US6270781 Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors |
| 08/07/2001 | US6270768 Azithromycins |
| 08/07/2001 | US6270766 Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease |
| 08/07/2001 | US6270755 Anionic polymers as toxin binders |
| 08/07/2001 | US6270752 Based on essential oils obtainable through alcoholic distillation of plants which contain the essential oils, combined with salicylic acid and with fatty acids having 10 to 40 carbon atoms. |
| 08/07/2001 | US6270750 Proline-, glycine- and lysine-based pharmaceutical composition useful in dental treatment both in the injectable form and in the formulation for topical use |
| 08/07/2001 | US6270747 Inhibiting hypersecretion of mucus in lungs and airways by the administration of an egf-r antagonist. |
| 08/07/2001 | CA2297944A1 The groups with anticancer activity and the method of making their derivatives |
| 08/07/2001 | CA2297933A1 A method to improve immune function |
| 08/07/2001 | CA2213197C Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands |
| 08/07/2001 | CA2211006C Topically applied pharmaceutical composition, method of preparing it and its use |
| 08/07/2001 | CA2193520C Use of procysteine as a depigmentation agent |
| 08/07/2001 | CA2167044C Oral administration of effective amounts of forms of hyaluronic acid |
| 08/07/2001 | CA2145242C Oral pharmaceutical preparation |
| 08/07/2001 | CA2139217C Vaccine composition for eliciting an immune response against n-glycolylated gangliosides and its use for cancer treatment |